ANAVEX LIFE SCIENCES CORP. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ANAVEX LIFE SCIENCES CORP. on February 7, 2011, reporting an event that occurred on February 2, 2011. The company is incorporated in Nevada and maintains its principal executive offices in Hoboken, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event rather than financial performance.
Material Changes
On February 2, 2011, the company amended and restated its 2007 Stock Option Plan. The primary material change is the increase in the number of shares authorized under the plan to 4,000,000.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to disclose the amendment to the stock option plan.
Key Facts for Investor Verification
- The 2007 Stock Option Plan was amended to authorize 4,000,000 shares.
- The full text of the Amended and Restated 2007 Stock Option Plan is attached as Exhibit 99.1.
- The report was signed by Harvey Lalach, President, Chief Operating Officer, and Director.